2019 International Congress

September 22-26, 2019. Nice, France.

View by Title View Sessions

View by Date

Jump to: [View All] • a b c d e f g h i j k l m n o p q r s t u v w x y z

Retinal thickness and microvascular pattern in early Parkinson’s disease.

C. Rascunà, C. Terravecchia, A. Russo, G. Mostile, CE. Cicero, A. Luca, N. Castellino, A. Longo, T. Avitabile, M. Reibaldi, M. Zappia, A. Nicoletti (Catania, Italy)
Retronasal olfactory function in Parkinson’s disease

E. Aubry-Lafontaine, C. Tremblay, P. Durand-Martel, N. Dupré, J. Frasnelli (Trois-Rivières, QC, Canada)
Retrospective analysis of hospitalized Parkinson ‘s disease patients from 2002 to 2014 in Suzhou district

C. Mao, J. Chen, H. Gu, D. Chen, J. Huang, J. Chen, Y. Wang, W. Luo, C. Liu (Changshu, China)
Reverse phenotyping of a 3.3Mb loss of 8p11.21p11.1, including SLC20A2, lead to a diagnosis of primary familial brain calcification

A. Kievit, L. Zutven, A. Boon (Rotterdam, Netherlands)
Reviewing the clinical and mutational spectrum of SLC20A2, PDGFB, PDGFRB, XPR1 and MYORG mutations in Primary Familial Brain Calcification (PFBC) for MDSGene

A. Balck, S. Schaake, J. Margolesky, A. Domingo, C. Klein, A. Westenberger (Lubeck, Germany)
Rhythmic disorders in idiopathic RBD: a potential new marker for future PD?

V. Cochen Decock, D. Verbizier, C. Geny, S. Dalla Bella (Montpellier, France)
RimbotulinumtoxinB in the treatment of adult sialorrhea

S. Isaacson, W. Ondo, M. Lew, K. Dashtipour, D. Chary, T. Clinch, F. Pagan (Boca Raton, FL, USA)
Risk of developing the Parkinson’s disease against the background of diabetes mellitus type 2.

F. Akhmedova, M. Tukhtamishev (Tashkent, Uzbekistan)
Risk of Parkinson’s in idiopathic anosmia

R. Rees, S. Gane, C. Philpott, A. Noyce, A. Schrag (Norwich, United Kingdom)
Risk Thresholds of Levodopa Dose for Dyskinesia in Chinese Patients with Parkinson’s Disease: A Pilot Study

GL. Liu, T. Feng (Beijing, China)

Jump to: [View All] • a b c d e f g h i j k l m n o p q r s t u v w x y z